On Wednesday, Option Care Health received an upgrade to its Relative Strength (RS) Rating, from 64 to 73.
When To Sell Stocks To Lock In Profits And Minimize Losses
IBD's unique RS Rating measures technical performance by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.
Decades of market research reveals that the stocks that go on to make the biggest gains tend to have an RS Rating of at least 80 in the early stages of their moves. See if Option Care Health can continue to rebound and clear that threshold.
Option Care Health is working on a consolidation with a 35.53 buy point. See if it can break out in volume at least 40% above average.
Option Care Health posted 14% earnings growth last quarter, while sales growth came in at 16%.
Option Care Health earns the No. 5 rank among its peers in the Medical-Services industry group. Hims & Hers Health is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
